Medline Inc. logo MDLN - Medline Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 12
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $48.55 DETAILS
HIGH: $60.00
LOW: $38.00
MEDIAN: $48.00
CONSENSUS: $48.55
UPSIDE: 20.47%

Stock News

MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations

MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations

SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols—specifically failures to investigate microbial incidents and batch discrepancies—that prompted regulatory scrutiny and triggered a significant decline in the company's share price.

Jul 01, 2026 11:45 AM • globenewswire.com (Hide legal announcements)
Medline: After IPO In 2025, This Year Is A Bet On Continued Growth

Medline: After IPO In 2025, This Year Is A Bet On Continued Growth

Medline Inc. is rated a buy, driven by robust sector macroeconomics, strong ROE, organic Q1 growth, and a favorable Fitch investment-grade rating. MDLN's top-line growth is compelling, with net sales up 10.7% YoY, fueled by new customer signings and international market penetration. Despite positive revenue trends, MDLN faces margin pressure from rising costs, volatile cash flows, and a rich 37x forward earnings multiple, warranting caution.

Jun 30, 2026 02:06 AM • seekingalpha.com
Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters

Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (“AVI”), a medical device company specializing in developing advanced vascular access solutions, and Medline, the largest provider of medical-surgical products and supply chain solutions serving all points of care, today announced a multi-year agreement to accelerate the rollout of AVI's next-generation catheters, HydroMID® and HydroPICC®, which recently received an anti-thrombogenic indication from the FDA. The initiative bolsters Medlin.

Jun 23, 2026 03:04 AM • businesswire.com
MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medline Inc. ("Medline" or "the Company") (NASDAQ: MDLN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Jun 11, 2026 08:00 AM • prnewswire.com (Hide legal announcements)
MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medline Inc. (“Medline” or “the Company”) (NASDAQ: MDLN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Jun 10, 2026 06:12 AM • globenewswire.com (Hide legal announcements)
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDLINE INDUSTRIES, INC. (MDLN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What H.

Jun 09, 2026 08:00 AM • businesswire.com (Hide legal announcements)
Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDLINE INDUSTRIES, INC. (MDLN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal r.

Jun 09, 2026 05:00 AM • businesswire.com (Hide legal announcements)
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDLINE INDUSTRIES, INC. (MDLN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On June 2, 2026, the FDA published a warning letter address.

Jun 08, 2026 11:35 AM • businesswire.com (Hide legal announcements)

Price Targets